Controversies in the Surgical Management of Gynecologic Cancer: Balancing the Decision to Operate or Hesitate

• Published in: American Society of Clinical Oncology educational book Vol. 44; no. 3; p. e438550
• Main Authors: Somasegar, Sahana, Anastasio, Mary Katherine, Karam, Amer, Rossi, Emma C, Obermair, Andreas
• Format: Journal Article
• Language: English
• Published: United States 01-06-2024
• Subjects: Female; Genital Neoplasms, Female - surgery; Gynecologic Surgical Procedures - methods; Humans; Neoplasm Staging; Quality of Life
• ISSN: 1548-8756
• DOI: 10.1200/EDBK_438550

Cancer outcomes are largely measured in terms of disease-free survival or overall survival, which is highly dependent on timely diagnosis and access to treatment methods available within the country's existing health care system. Although cancer survival rates have markedly led in the past few decades, any improvement in the 5-year survival of gynecologic cancers has been modest, as in the case of ovarian and cervical cancers, or has declined, as in the case of endometrial cancer. The lack of effective screening options contributes to many women presenting with advanced-stage disease and the need for radical approaches to treatment. Although treatment for early-stage disease can lead to a cure, advanced-stage disease is fraught with a high potential for morbidity and mortality, and recent clinical trials have aimed to assess the noninferiority of minimally invasive options versus aggressive surgical approaches. Of particular interest is fertility-sparing treatments for endometrial and cervical cancers, which have recently been on the rise among younger women. Balancing morbidity with the risk of mortality, and loss of fertility and quality of life requires a targeted patient-centered approach to treatment. This is an ongoing area of intense research and sometimes may challenge current treatment paradigms. In this two-part review, we present an overview of current approaches to gynecologic cancer treatment and the need to de-escalate radical surgical approaches and preserve fertility. We also review the intricacies of ovarian and advanced endometrial cancer treatment, exploring the nuances in surgical debulking timing and its impact on outcomes.